136 related articles for article (PubMed ID: 1668175)
1. Effects of uremic serum on 1,25-dihydroxyvitamin D3-induced differentiation of a human promyelocytic leukemia cell line, HL-60.
Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H
J Nutr Sci Vitaminol (Tokyo); 1991 Dec; 37 Suppl():S93-103. PubMed ID: 1668175
[TBL] [Abstract][Full Text] [Related]
2. Effect of uremic serum on 1,25-dihydroxyvitamin D3-induced differentiation of human promyelocytic leukemia cell, HL-60.
Inaba M; Okuno S; Koyama H; Ishimura E; Nishizawa Y; Morii H
Nephron; 1993; 63(2):152-8. PubMed ID: 8383808
[TBL] [Abstract][Full Text] [Related]
3. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H
Arch Biochem Biophys; 1992 Feb; 293(1):181-6. PubMed ID: 1309983
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
Mangelsdorf DJ; Koeffler HP; Donaldson CA; Pike JW; Haussler MR
J Cell Biol; 1984 Feb; 98(2):391-8. PubMed ID: 6319426
[TBL] [Abstract][Full Text] [Related]
5. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
Honda A; Nakashima N; Mori Y; Katsumata T; Ishizuka S
J Steroid Biochem Mol Biol; 1992 Jan; 41(1):109-12. PubMed ID: 1310414
[TBL] [Abstract][Full Text] [Related]
6. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
[TBL] [Abstract][Full Text] [Related]
7. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of thromboxane synthesis by novel 26,27-dialkyl analogues of 1 alpha,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells.
Honda A; Mori Y; Ikekawa N; Raz A
Eur J Pharmacol; 1992 Dec; 229(2-3):217-22. PubMed ID: 1337046
[TBL] [Abstract][Full Text] [Related]
9. Monocytic differentiation of acute promyelocytic leukemia cells in response to 1,25-dihydroxyvitamin D3 is independent of nuclear receptor binding.
Bhatia M; Kirkland JB; Meckling-Gill KA
J Biol Chem; 1995 Jul; 270(27):15962-5. PubMed ID: 7608152
[TBL] [Abstract][Full Text] [Related]
10. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
11. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
12. Promotion of HL-60 cell differentiation by 1,25-dihydroxyvitamin D3 regulation of protein kinase C levels and activity.
Pan Q; Granger J; O'Connell TD; Somerman MJ; Simpson RU
Biochem Pharmacol; 1997 Oct; 54(8):909-15. PubMed ID: 9354591
[TBL] [Abstract][Full Text] [Related]
13. Regulation of 25-hydroxyvitamin D3 metabolism in a human promyelocytic leukemia cell line (HL-60): 1,25-dihydroxyvitamin D3 stimulates the synthesis of 24,25-dihydroxyvitamin D3.
Reichel H; Koeffler HP; Norman AW
Arch Biochem Biophys; 1986 Nov; 251(1):222-31. PubMed ID: 3024572
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of NaF-induced differentiation of HL-60 cells.
Kawase T; Oguro A; Orikasa M; Burns DM
J Bone Miner Res; 1996 Nov; 11(11):1676-87. PubMed ID: 8915775
[TBL] [Abstract][Full Text] [Related]
15. Significance of proteolytic activity in 1,25-(OH)2D3-induced differentiation of HL-60 cells.
Inaba M; Morii H; DeLuca HF
Contrib Nephrol; 1991; 91():102-8. PubMed ID: 1666029
[TBL] [Abstract][Full Text] [Related]
16. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.
Taoka T; Collins ED; Irino S; Norman AW
Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
[TBL] [Abstract][Full Text] [Related]
19. 1,25-Dihydroxyvitamin D3 promotes prostaglandin E1-induced differentiation of HL-60 cells.
Kawase T; Ogata S; Orikasa M; Burns DM
Calcif Tissue Int; 1995 Nov; 57(5):359-66. PubMed ID: 8564798
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism.
Zhou JY; Norman AW; Akashi M; Chen DL; Uskokovic MR; Aurrecoechea JM; Dauben WG; Okamura WH; Koeffler HP
Blood; 1991 Jul; 78(1):75-82. PubMed ID: 1648977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
